Loading clinical trials...
Loading clinical trials...
This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.
The goal of this single-arm pilot study is to test the TRIAL web application which is designed to reduce inequity in clinical trial enrollment among participants with acute leukemia. The application aims to facilitate access to clinical trials and reduce barriers for underrepresented groups. The research study procedures include screening for eligibility and questionnaires. Participation in this research study is expected to last about 14 weeks. It is expected about 75 people will participate in this study. The National Cancer Institute (NCI) and American Society of Clinical Oncology (ASCO) are providing funding for this study.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
April 1, 2025
Primary Completion Date
July 1, 2026
Completion Date
June 30, 2027
Last Updated
May 20, 2025
75
ESTIMATED participants
TRIAL Web-Based Application
BEHAVIORAL
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT00106925